© 2020 HealthCom Media
All rights reserved. No part of this website or publication may be reproduced, stored, or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the copyright holder
Home 2016
Archives
Understanding radiation dermatitis
According to the National Cancer Institute, an estimated 1.6 million new cases of cancer will have been diagnosed in the United States in 2015....
From our readers: When your parent is the patient
It’s not easy when your parent is the patient. In my 10 years of being a registered nurse, I have learned a lot, seen...
Long-term cancer survivorship nurse practitioner care model promotes patient quality of life
It’s not uncommon for cancer patients to say they classify themselves as a cancer survivor by having lived at least 5 years past the...
Brushing up on mouth care for cancer patients with mucositis
Chemotherapy and radiation used to treat head and neck cancers, as well as high-dose chemotherapy given to stem-cell transplant patients, can damage the mucosa...
Breast cancer care gets personal
Learning objectives
1. State how breast cancer is diagnosed and evaluated.
2. Identify the implications of genetics for patients with breast cancer.
3. Discuss targeted therapy for...
When good people make hard choices…*
Leah Curtin discusses the difficulty of making choices in health care and includes a challenging situation she experienced as a student.
FDA approves drug for treating rare type of non-Hodgkin lymphoma
On July 3, the U.S. Food and Drug Administration (FDA) approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma, a rare...
FDA approves new indication for imaging agent
On June 13, the U.S. Food and Drug Administration (FDA) a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent...
FDA approves Zykadia for NSCLC
On April 29, the U.S. Food and Drug Administration (FDA) approved Zykadia for patients with a certain type of late-stage non-small cell lung cancer...
FDA approves Impavido to treat leishmaniasis
On March 19, the U.S. Food and Drug Administration (FDA) approved Impavido (miltefosine) to treat a tropical disease called leishmaniasis. Read more.
FDA approves Imbruvica to treat chronic lymphocytic leukemia
On Feb. 13, the U.S. Food and Drug Administration (FDA) expanded the approved use of Imbruvica (ibrutinib) for chronic lymphocytic leukemia patients who have...
Study: Radiation therapy skin reactions may be preventable
Severe skin reactions during radiation therapy could be prevented by applying a thin transparent silicone dressing to the skin from the first day of...
Study: Melanoma increases among middle-aged adults
A study in Mayo Clinic Proceedings reports that the incidence of cutaneous melanoma among middle-aged adults (40 to 60 years) has increased nearly eightfold...